"Alzheimer's Diagnosis Overhaul: Adopting Cancer-like Rating Scale"

Alzheimer's disease experts have introduced a new seven-point rating scale for diagnosing patients with the progressive brain disorder. The scale, similar to the one used in cancer diagnoses, assesses disease progression based on cognitive and biological changes in the patient. The new guidelines aim to be more accurate and reflect a person's underlying disease, taking into account the availability of tests detecting Alzheimer's-related proteins and new treatments that require confirmation of disease pathology. The scale includes stages ranging from asymptomatic with abnormal biomarkers to severe dementia, and also includes a stage for individuals with genes guaranteeing the development of Alzheimer's. The new guidelines will aid doctors in offering personalized treatments that can slow the course of the disease.